Presented
by

Presented by Oxford Global

Discover PLUS Pass

Next Up

Immuno 2024

25 - 26 April 2024 |

London, UK

25 - 26 April 2024

London, UK

A two-day event packed with leading speakers, research and cutting-edge presentations on the latest advancements in cancer immunotherapy, with dedicated sessions o n different therapeutic modalities as well as case studies on innovative preclinical and translational tools.

> Visit Event Website

07 Dec 2023
Thu, 07 December 2023

Uncovering Mechanisms of Immunotherapy Response and Resistance with Single Cell and Spatial Multiomics Webinar

Presented by Abbey Cutchin, Associate Director, Oncology Marketing, 10x Genomics

> Register Interest

Oct 2024
October 2024

Immuno US 2024

> Visit Event Website

> See All Upcoming Oxford Global Immuno Events
> See All Webinars & Recordings

Highlights

Angelica Loskog, CEO, Lokon Pharma (featured)
Industry Spotlight
Immunostimulatory Oncolytic Viruses: Interview with Angelica Loskog, CEO, Lokon Pharma
Diving deep into Lokon Pharma's immunostimulatory oncolytic virus programme. Learn about their LOAd platform, transition to the clinic, and more.
Edited by Tom Cohen |
14 November 2023
Therapeutic Modalities
Industry Spotlight
The Therapeutic Modulation of Cytokines with Pierre Ferré, VP of Pre-Clinical Development, Compugen
13 Nov 2023
Tumour Microenvironment
Industry Spotlight
Positive Phase I Data from Oncolytic Virotherapy Trial
Edited by Tom Cohen |
07 Nov 2023
Tumour Microenvironment

In-Depth

Understanding and Overcoming the Immunosuppressive TME
Insight Article
Understanding and Overcoming the Immunosuppressive TME
Explore the intricate world of the immunosuppressive tumor microenvironment (TME), a key player in cancer progression and treatment resistance
08 December 2023
ynergistic Effects When Combining Immuno-Oncology Treatments
Insight Article
Immuno-Oncology Vs Chemotherapy: Exploring Treatment Synergies
Unpacking the potential of combining immuno-oncology and chemotherapy: understanding benefits, real-world impact, and addressing concerns.
18 September 2023
NK Cell Therapies: Development, Application, and Challenges
Insight Article
NK Cell Therapies: Development, Application, and Challenges
Sourcing NK cells, expansion techniques, gene modification, quality control, safety, preservation, and delivery.
22 August 2023
Exploring Oncology Biomarkers in Early Clinical Trials and Precision Medicine
Insight Article
Exploring Oncology Biomarkers in Early Clinical Trials and Precision Medicine: Challenges and Opportunities
The importance of validating hypotheses, understanding the biology of cancer progression, and utilising biomarkers in early screening to stratify populations and improve clinical endpoints.
14 August 2023
> See All

Industry Spotlight

Angelica Loskog, CEO, Lokon Pharma (featured)
Industry Spotlight
Immunostimulatory Oncolytic Viruses: Interview with Angelica Loskog, CEO, Lokon Pharma
Diving deep into Lokon Pharma's immunostimulatory oncolytic virus programme. Learn about their LOAd platform, transition to the clinic, and more.
14 November 2023
Oncolytic Virus Immunotherapy
Industry Spotlight
Oncolytic Virus Immunotherapy: A Revolutionary Approach in Immuno-Oncology
Explore the cutting-edge of oncolytic virus immunotherapy in immuno-oncology: the viruses revolutionizing cancer treatment and the promise they hold for future therapies.
14 November 2023
Interview - Pierre Ferre, VP of Pre-Clinical Development, Compugen
Industry Spotlight
The Therapeutic Modulation of Cytokines with Pierre Ferré, VP of Pre-Clinical Development, Compugen
Compugen's candidate therapeutic, COM503, targets interleukin-18 binding protein to unleash interleukin-18's immunostimulatory power.
13 November 2023
Positive Phase I Data from Oncolytic Virus Trial
Industry Spotlight
Positive Phase I Data from Oncolytic Virotherapy Trial
TILT-123, an oncolytic virotherapy, has shown promising results from a phase I clinical trial which treats solid tumours in patients that have exhausted other options.
07 November 2023
> See All

[sponsor section - bespoke content]

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Immuno

> Register